US Stock MarketDetailed Quotes

CYCC Cyclacel Pharmaceuticals

Watchlist
  • 0.4050
  • +0.0600+17.39%
Close Nov 29 13:00 ET
  • 0.4200
  • +0.0150+3.70%
Post 16:57 ET
2.55MMarket Cap-14P/E (TTM)

Cyclacel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
24.01%-3.07M
-136.32%-3.08M
92.96%-483K
22.64%-16.11M
24.36%-3.91M
42.08%-4.04M
31.85%-1.31M
-1.27%-6.86M
-12.34%-20.83M
-13.63%-5.17M
Net income from continuing operations
67.56%-1.96M
40.22%-3.26M
49.24%-2.95M
-6.40%-22.56M
28.95%-5.27M
-18.37%-6.03M
-19.08%-5.45M
-41.29%-5.8M
-14.85%-21.2M
-52.53%-7.42M
Depreciation and amortization
-85.71%1K
-75.00%2K
-75.00%2K
-3.13%31K
0.00%8K
0.00%7K
0.00%8K
-11.11%8K
-25.58%32K
14.29%8K
Other non cash items
66.67%-5K
-14.29%-16K
38.46%-16K
----
----
---15K
---14K
-73.33%-26K
----
----
Change In working capital
-175.20%-1.21M
-100.05%-2K
257.92%2.27M
523.22%4.94M
-47.39%976K
171.12%1.61M
65.72%3.79M
52.65%-1.44M
9.04%-1.17M
46,275.00%1.86M
-Change in prepaid assets
-189.33%-67K
-74.00%1.18M
263.70%2.02M
224.52%4.71M
239.26%1.35M
103.97%75K
41.34%4.52M
70.09%-1.23M
15.54%-3.78M
46.96%-968K
-Change in payables and accrued expense
-174.51%-1.15M
-60.71%-1.18M
223.30%254K
-88.51%296K
-110.78%-303K
477.89%1.54M
19.72%-733K
-118.99%-206K
-14.81%2.58M
53.66%2.81M
-Change in other current liabilities
----
----
----
-272.50%-69K
----
----
----
----
-76.74%40K
1,200.00%11K
Cash from discontinued investing activities
Operating cash flow
24.01%-3.07M
-136.32%-3.08M
92.96%-483K
22.64%-16.11M
24.36%-3.91M
42.08%-4.04M
31.85%-1.31M
-1.27%-6.86M
-12.34%-20.83M
-13.63%-5.17M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
14.29%-6K
0
0
0
-50.00%-6K
74.07%-7K
0
Net PPE purchase and sale
--0
--0
--0
14.29%-6K
--0
--0
--0
-50.00%-6K
74.07%-7K
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
14.29%-6K
--0
--0
--0
-50.00%-6K
74.07%-7K
--0
Financing cash flow
Cash flow from continuing financing activities
98.00%-1K
12,431.37%6.29M
-58.00%-79K
-71.71%848K
2,278.57%999K
-103.26%-50K
-103.46%-51K
0.00%-50K
-86.21%3M
-95.26%42K
Net common stock issuance
---1K
----
----
-67.21%1.05M
1,040.22%1.05M
--0
----
----
-81.58%3.2M
102.53%92K
Cash dividends paid
--0
--0
--0
0.00%-201K
0.00%-50K
0.00%-50K
0.00%-51K
0.00%-50K
0.00%-201K
0.00%-50K
Net other financing activities
----
----
---79K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
98.00%-1K
12,431.37%6.29M
-58.00%-79K
-71.71%848K
2,278.57%999K
-103.26%-50K
-103.46%-51K
0.00%-50K
-86.21%3M
-95.26%42K
Net cash flow
Beginning cash position
-40.97%6M
-75.53%2.8M
-81.59%3.38M
-49.82%18.35M
-74.93%5.94M
-65.04%10.16M
-61.42%11.44M
-49.82%18.35M
9.44%36.56M
-41.06%23.71M
Current changes in cash
24.91%-3.07M
336.36%3.21M
91.88%-562K
14.39%-15.27M
43.22%-2.91M
24.83%-4.09M
-205.41%-1.36M
-1.29%-6.92M
-662.65%-17.84M
-39.93%-5.13M
Effect of exchange rate changes
137.31%50K
-103.53%-3K
-357.14%-18K
180.16%303K
247.44%345K
-306.15%-134K
172.03%85K
107.69%7K
-2,123.53%-378K
-5,950.00%-234K
End cash Position
-49.83%2.98M
-40.97%6M
-75.53%2.8M
-81.59%3.38M
-81.59%3.38M
-74.93%5.94M
-65.04%10.16M
-61.42%11.44M
-49.82%18.35M
-49.82%18.35M
Free cash flow
24.01%-3.07M
-136.32%-3.08M
92.97%-483K
22.64%-16.12M
24.36%-3.91M
42.08%-4.04M
31.96%-1.31M
-1.30%-6.87M
-12.21%-20.83M
-13.58%-5.17M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 24.01%-3.07M-136.32%-3.08M92.96%-483K22.64%-16.11M24.36%-3.91M42.08%-4.04M31.85%-1.31M-1.27%-6.86M-12.34%-20.83M-13.63%-5.17M
Net income from continuing operations 67.56%-1.96M40.22%-3.26M49.24%-2.95M-6.40%-22.56M28.95%-5.27M-18.37%-6.03M-19.08%-5.45M-41.29%-5.8M-14.85%-21.2M-52.53%-7.42M
Depreciation and amortization -85.71%1K-75.00%2K-75.00%2K-3.13%31K0.00%8K0.00%7K0.00%8K-11.11%8K-25.58%32K14.29%8K
Other non cash items 66.67%-5K-14.29%-16K38.46%-16K-----------15K---14K-73.33%-26K--------
Change In working capital -175.20%-1.21M-100.05%-2K257.92%2.27M523.22%4.94M-47.39%976K171.12%1.61M65.72%3.79M52.65%-1.44M9.04%-1.17M46,275.00%1.86M
-Change in prepaid assets -189.33%-67K-74.00%1.18M263.70%2.02M224.52%4.71M239.26%1.35M103.97%75K41.34%4.52M70.09%-1.23M15.54%-3.78M46.96%-968K
-Change in payables and accrued expense -174.51%-1.15M-60.71%-1.18M223.30%254K-88.51%296K-110.78%-303K477.89%1.54M19.72%-733K-118.99%-206K-14.81%2.58M53.66%2.81M
-Change in other current liabilities -------------272.50%-69K-----------------76.74%40K1,200.00%11K
Cash from discontinued investing activities
Operating cash flow 24.01%-3.07M-136.32%-3.08M92.96%-483K22.64%-16.11M24.36%-3.91M42.08%-4.04M31.85%-1.31M-1.27%-6.86M-12.34%-20.83M-13.63%-5.17M
Investing cash flow
Cash flow from continuing investing activities 00014.29%-6K000-50.00%-6K74.07%-7K0
Net PPE purchase and sale --0--0--014.29%-6K--0--0--0-50.00%-6K74.07%-7K--0
Cash from discontinued investing activities
Investing cash flow --0--0--014.29%-6K--0--0--0-50.00%-6K74.07%-7K--0
Financing cash flow
Cash flow from continuing financing activities 98.00%-1K12,431.37%6.29M-58.00%-79K-71.71%848K2,278.57%999K-103.26%-50K-103.46%-51K0.00%-50K-86.21%3M-95.26%42K
Net common stock issuance ---1K---------67.21%1.05M1,040.22%1.05M--0---------81.58%3.2M102.53%92K
Cash dividends paid --0--0--00.00%-201K0.00%-50K0.00%-50K0.00%-51K0.00%-50K0.00%-201K0.00%-50K
Net other financing activities -----------79K----------------------------
Cash from discontinued financing activities
Financing cash flow 98.00%-1K12,431.37%6.29M-58.00%-79K-71.71%848K2,278.57%999K-103.26%-50K-103.46%-51K0.00%-50K-86.21%3M-95.26%42K
Net cash flow
Beginning cash position -40.97%6M-75.53%2.8M-81.59%3.38M-49.82%18.35M-74.93%5.94M-65.04%10.16M-61.42%11.44M-49.82%18.35M9.44%36.56M-41.06%23.71M
Current changes in cash 24.91%-3.07M336.36%3.21M91.88%-562K14.39%-15.27M43.22%-2.91M24.83%-4.09M-205.41%-1.36M-1.29%-6.92M-662.65%-17.84M-39.93%-5.13M
Effect of exchange rate changes 137.31%50K-103.53%-3K-357.14%-18K180.16%303K247.44%345K-306.15%-134K172.03%85K107.69%7K-2,123.53%-378K-5,950.00%-234K
End cash Position -49.83%2.98M-40.97%6M-75.53%2.8M-81.59%3.38M-81.59%3.38M-74.93%5.94M-65.04%10.16M-61.42%11.44M-49.82%18.35M-49.82%18.35M
Free cash flow 24.01%-3.07M-136.32%-3.08M92.97%-483K22.64%-16.12M24.36%-3.91M42.08%-4.04M31.96%-1.31M-1.30%-6.87M-12.21%-20.83M-13.58%-5.17M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-6.28%